ITMI20031201A1 - Epitopi della proteina pp65 di citomegalovirus - Google Patents

Epitopi della proteina pp65 di citomegalovirus

Info

Publication number
ITMI20031201A1
ITMI20031201A1 IT001201A ITMI20031201A ITMI20031201A1 IT MI20031201 A1 ITMI20031201 A1 IT MI20031201A1 IT 001201 A IT001201 A IT 001201A IT MI20031201 A ITMI20031201 A IT MI20031201A IT MI20031201 A1 ITMI20031201 A1 IT MI20031201A1
Authority
IT
Italy
Prior art keywords
citomegalovirus
epitopes
protein
Prior art date
Application number
IT001201A
Other languages
English (en)
Inventor
Laura Bottone
Pira Giuseppina Li
Fabrizio Manca
Original Assignee
Istituto Giannina Gaslini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Giannina Gaslini filed Critical Istituto Giannina Gaslini
Priority to IT001201A priority Critical patent/ITMI20031201A1/it
Publication of ITMI20031201A0 publication Critical patent/ITMI20031201A0/it
Priority to PCT/IB2004/001918 priority patent/WO2004111080A1/en
Publication of ITMI20031201A1 publication Critical patent/ITMI20031201A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/13—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT001201A 2003-06-13 2003-06-13 Epitopi della proteina pp65 di citomegalovirus ITMI20031201A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT001201A ITMI20031201A1 (it) 2003-06-13 2003-06-13 Epitopi della proteina pp65 di citomegalovirus
PCT/IB2004/001918 WO2004111080A1 (en) 2003-06-13 2004-06-10 Epitopes of the cytomegalovirus pp65 protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001201A ITMI20031201A1 (it) 2003-06-13 2003-06-13 Epitopi della proteina pp65 di citomegalovirus

Publications (2)

Publication Number Publication Date
ITMI20031201A0 ITMI20031201A0 (it) 2003-06-13
ITMI20031201A1 true ITMI20031201A1 (it) 2004-12-14

Family

ID=30131210

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001201A ITMI20031201A1 (it) 2003-06-13 2003-06-13 Epitopi della proteina pp65 di citomegalovirus

Country Status (2)

Country Link
IT (1) ITMI20031201A1 (it)
WO (1) WO2004111080A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3888675A1 (en) 2013-09-24 2021-10-06 Duke University Compositions, methods and kits for eliciting an immune response
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
WO2019061297A1 (zh) 2017-09-29 2019-04-04 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI871709B (zh) 2020-06-21 2025-02-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽
CN118221773B (zh) * 2024-02-05 2025-09-09 首都医科大学附属北京儿童医院保定医院 与HLA相关的CMV pp65表位疫苗组合物与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041442B1 (en) * 1999-06-04 2006-05-09 Florian Kern Peptides for vaccinating against human CMV
DE10009341A1 (de) * 2000-02-22 2001-09-06 Florian Kern Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
EP1483575A2 (en) * 2002-02-28 2004-12-08 Intercell AG Methods for isolating ligands e.g. t cell epitopes

Also Published As

Publication number Publication date
ITMI20031201A0 (it) 2003-06-13
WO2004111080A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
IS8266A (is) Breytt mennsk IGF-1R mótefni
CY2016035I1 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
DE602004026768D1 (de) Therapeutische anti-igfr1-antikörper-kombinationen
DK1599504T3 (da) Modificeret antistof
PT2364729E (pt) Anticorpos antagonísticos de il-17
NO20044347L (no) Anti-alfavbeta6-antistoff
HRP20151252T4 (hr) Modificirani fab ulomci protutijela
EP1616881A4 (en) ANTI-MPL ANTIBODY
DK1610780T4 (da) Cykliske protein-tyrosin-kinasehæmmere
DE602004022855D1 (de) Interleukin-10-antikörper
PT2784084T (pt) Anticorpos antagonistas contra polipéptidos heterólogos il-17a/f
EP1499352A4 (en) RECOMBINANT ANTI-INTERLEUKIN-9 ANTIBODIES
DK1689775T3 (da) GAG-bindende proteiner
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
ATE490756T1 (de) Kosmetisches unterarm-verfahren
EP1660436A4 (en) cathepsin inhibitors
DE602004010354D1 (de) Medienwegleitmodul
EP1460900A4 (en) Human secreted proteins
AR028261A1 (es) Inhibidores triciclicos de la proteina quinasa
NO20034452L (no) Sykdoms-assosiert protein
EP1598368A4 (en) ANTI-PCI neutralizing ANTIBODY
ATE513564T1 (de) Immunogener rekombinanter antikörper
FI20030778A0 (fi) Taudin määrittäminen tai ennustaminen
EP1682572A4 (en) Protein Expression
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika